LSE logo Many people think of investing as buying shares in companies listed on a stock exchange, but there is a parallel universe of investments in private companies. Worldwide, there are 39,000 private equity funds that invest in startups or established firms, aiming to grow the businesses so they can be floated on the stock market, or sold to a trade buyer or another investor. Most of these funds require big sums to invest. On the London Stock Exchange though, there are 40 private equity funds whose shares can be bought easily like any other through a stockbroker. We tipped one, the specialist early-stage investor Augmentum Fintech, in December. However, these funds operate across a broad range of sectors and countries, investing in companies either directly or through other private equity funds. The market is remarkably polarised. On the one hand is the giant 3i Group, whose £18bn portfolio accounts for nearly half of the £39bn in the sector. Its share price stands at a huge 31pc premium above asset value, reflecting strong investor demand after it trebled shareholders’ money over the past five years. The other 39 funds are rather neglected, their shares consistently stuck below net asset value (NAV) despite impressive long-term performance. Although none comes close to 3i’s incredible 776pc shareholder return over 10 years, the average private equity ‘fund of funds’ hasn’t done badly with 232pc, while the average direct private equity fund posted a gain of 275pc. These figures compare well with global public stock markets and are much better than the FTSE All-Share index’s return of 65pc. Despite this, private equity funds apart from 3i stand at an average 24pc discount to NAV. There are several causes: painful memories of the 2008 global financial crisis, when some funds crashed; regulations that inflate these funds’ charges and make them appear prohibitively expensive; and suspicion of the three-to-six-month delay in valuing their assets. The latter has led to fears that the funds could go over a ‘cliff edge’ if their stakes in unquoted companies are written down in the challenging economic environment. City analysts believe this to be unlikely because private equity-backed firms have continued to grow profits, while the stock market rally at the end of last year gives them a positive yardstick by which to measure their businesses. Private equity funds generate their returns by eventually selling stakes in their holdings, frequently on big uplifts to their previous valuation. Last year these ‘exits’ dropped off as buyers grew more cautious but could revive if interest rates fall and confidence returns. Analysts at the broker Stifel said this pause left many private equity funds “pregnant” with potential gains from investments made five or more years ago. “Assuming realisations at gains over prior valuations, this will help NAV growth” and lead to higher share prices, they said. Oakley Capital Investments, a £1.2bn fund of funds from Oakley Capital tipped here in the past, is a popular analysts’ choice on a 31pc discount and with a 206pc 10-year return to its name. So is Pantheon International, another Questor tip. The £2.2bn portfolio of funds and companies languishes on a 34pc discount despite a £200m share buyback programme to boost shareholder returns and demonstrate confidence in its investments. But Questor’s current favourite is NB Private Equity, a £1bn investment company run by Neuberger Berman in New York, which has the pick of all the $120bn (£95bn) investments made by the group’s private equity funds. Its top holding and best long-term performer is the 6pc invested in Action, the rapidly growing European discount retailer that has turbocharged 3i. By co-investing almost all its portfolio directly in 86 private companies with 53 external fund managers, NBPE avoids shareholders paying two sets of fund fees. As a result, its 1.9pc annual ongoing charge is lower than the 3.4pc average of its closest rivals. It pays 3pc of assets in dividends each year, which, with the shares on a 28pc discount, puts them on a 4.7pc yield. Best of all, the maturity of the diversified portfolio – 70pc of its investments date back to 2019 or earlier – increases the likelihood of disposals this year. Although these may not be as profitable as in recent years, they could pep up performance, which has been modest in the past year, but over five and 10 years has delivered shareholders gains of 74pc and 287pc after all fund fees. As the board steps up share buybacks, Paul Daggett, a Neuberger managing director, says NBPE is “well positioned”. Questor agrees. Questor says: buy Ticker: NBPE Share price at close: £15.60 Recommended There is only one cure for Britain’s sickly stock market Read more
Private equity trusts are ‘pregnant’ with gains from investments made years ago
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...